Table of Contents
1. Executive Summary
2. Industry Introduction, including Taxonomy and Market Definition
3. Market Trends and Success Factors, including Macro-economic Factors, Market Dynamics, and Recent Industry Developments
4. Global Market Demand Analysis and Forecast, including Historical Analysis and Future Projections
5. Pricing Analysis
6. Global Market Analysis and Forecast
- 6.1. Product And Service
- 6.2. Major Market
7. Global Market Analysis and Forecast, By Product And Service
- 7.1. Others
- 7.2. Oncologics and Autoimmune
- 7.3. Hypertension and Diabetes
- 7.4. Antiulcerants and Pain
- 7.5. Dermatology and Antibiotics
- 7.6. Mental Health and Viral Hepatitis
- 7.7. Respiratory Health and Other CNS
- 7.8. HIV Antivirals and Cholesterol
8. Global Market Analysis and Forecast, By Major Market
- 8.1. Consumers In Developed Markets
- 8.2. Consumers In Pharmerging Markets
- 8.3. Consumers In The Rest Of The World (RoW)
9. Global Market Analysis and Forecast, By Region
- 9.1. North America
- 9.2. Latin America
- 9.3. Western Europe
- 9.4. Eastern Europe
- 9.5. Asia Pacific
- 9.6. East Asia
- 9.7. MEA
10. North America Sales Analysis and Forecast, by Key Segments and Countries
11. Latin America Sales Analysis and Forecast, by Key Segments and Countries
12. Western Europe Sales Analysis and Forecast, by Key Segments and Countries
13. Eastern Europe Sales Analysis and Forecast, by Key Segments and Countries
14. Asia Pacific Sales Analysis and Forecast, by Key Segments and Countries
15. East Asia Sales Analysis and Forecast, by Key Segments and Countries
16. MEA Sales Analysis and Forecast, by Key Segments and Countries
17. Sales Forecast by Products And Services and Major Markets for 30 Countries
18. Competition Outlook, including Market Structure Analysis, Company Share Analysis by Key Players, and Competition Dashboard
19. Company Profile
- 19.1. Pfizer Inc.
- 19.2. Johnson & Johnson
- 19.3. Roche Holding AG
- 19.4. Novartis AG
- 19.5. Merck & Co., Inc.
- 19.6. AbbVie Inc.
- 19.7. Sanofi
- 19.8. Bristol-Myers Squibb
- 19.9. GlaxoSmithKline (GSK)
- 19.10. AstraZeneca PLC
Who worked on this report
Preview the report firsthand - request a free sample
Free SampleGet the brochure for pricing and purchase details
Download PDF